𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome

✍ Scribed by Verstovsek, S; Kantarjian, H; Estey, E; Aguayo, A; Giles, F J; Manshouri, T; Koller, C; Estrov, Z; Freireich, E; Keating, M

Book ID
110054945
Publisher
Nature Publishing Group
Year
2001
Tongue
English
Weight
116 KB
Volume
15
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Plasma vascular endothelial growth facto
Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes
✍ Alvaro Aguayo; Hagop M. Kantarjian; Elihu H. Estey; Francis J. Giles; Srdan Vers πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 1 views

## Background: Vascular endothelial growth factor (vegf) and basic fibroblast growth factor (bfgf) are positive regulators of angiogenesis. increased levels in urine, serum, plasma, or malignant tissue have been associated with an adverse prognosis in patients with solid tumors. ## Methods: The a

Soluble vascular endothelial growth fact
Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes
✍ Qinglong Hu; Amanda L. Dey; Ying Yang; Yu Shen; Iman B. Jilani; Elihu H. Estey; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 257 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) are major regulators of angiogenesis, which plays a key role in the growth and dissemination of solid tumors and hematologic neoplasms. ## METHODS The authors measured the plasma concentrations of solu